scorecardresearch
Sunday, September 21, 2025
TopicCoronavirus vaccine

Topic: coronavirus vaccine

Pfizer-BioNTech Covid vaccine trial on track, CEO says study didn’t stop over safety concerns

Pfizer and BioNTech on track to potentially be the first to show the efficacy of a Covid-19 vaccine, in an environment of intense scrutiny over every possible complication.

Can inhaled vaccines provide better protection against coronavirus? Scientists look for answer

Covid-19 vaccines under development are injectable. Scientists are hoping for better immune responses with inhaled ones that directly target the nose & mouth.

Off The Cuff with Faheem Younus

Dr Faheem Younus, the Chief of Infectious Diseases at the University of Maryland, was the guest at ThePrint's Off the Cuff. Younus talked about...

Expert panel asks Dr Reddy’s to reapply for phase 2, 3 trials of Russian Covid vaccine

According to the CDSCO panel, the pharma company has to conduct both phase 2 and 3 clinical trials and cannot directly hold phase 3 trial for the vaccine in India, a source said.

AstraZeneca resumes Covid-19 vaccine trial in Japan, US still on hold

The phase 1 and 2 trials resumed after the Japanese regulator gave the go-ahead. Trials in the UK, Brazil, South Africa and India had already restarted in recent weeks.

Chinese vaccine maker to offer shots first to countries running phase 3 trials

Sinovac, one of three Chinese vaccines in the last stages of testing, is expecting interim data as soon as November from its Phase 3 trial of almost 10,000 people in Brazil.

UK is considering first-ever vaccine trials that expose people to coronavirus

The idea of challenge trials has gained momentum as the pathogen has spread around the world, but such tests exposing healthy people to the coronavirus also raise ethical questions.

Covid vaccine to be widely available in the US by April, CDC chief says

About 700 million vaccine doses should be available by April. The vaccine candidates that are furthest along in development will need a two-dose regimen, CDC chief Redfield said.

Covid vaccines developed outside India might need to undergo clinical trials here, says govt

Guidelines released by the Central Drugs Standard Control Organisation say clinical data generated outside India will be studied to determine the safety & effectiveness of the vaccine.

Reader View: People don’t have too many options but to trust a quickly-made Covid vaccine

YourTurn is our new weekly feature in which ThePrint's readers share their views or opinions in response to the question of the week.

On Camera

Skin cancer is no more an ‘old person’s disease’

The sun isn’t acting alone—it has an accomplice in pollution. Environmental toxins weaken our skin’s natural barrier.

Market regulator SEBI clears Adani Group of impropriety alleged by Hindenburg Research

SEBI probe concluded that purported loans and fund transfers were paid back in full and did not amount to deceptive market practices or unreported related party transactions.

60 yrs on, veterans recall lessons from 1965 India-Pakistan war. ‘Equipment alone doesn’t win battles’

A common thread runs through the memories of soldiers of the 1965 war—ingenuity, courage and camaraderie that withstood an apparently technologically superior foe.

India doesn’t give walkovers to Pakistan in war. Here’s why it shouldn’t do it in cricket either

Many really smart people now share the position that playing cricket with Pakistan is politically, strategically and morally wrong. It is just a poor appreciation of competitive sport.